The percentage of Texans without health insurance has dropped by 30 percent since the Affordable Care Act (ACA) went into effect, cutting the state’s uninsured rate below 1999 levels.
Elena M. Marks, Vivian Ho, Shao-Chee SimMay 31, 2016
State "right to try" laws can give terminally ill patients early access to experimental drugs and medical devices — but they arguably make safety and efficacy secondary to speedy access.
This blog post examines four factors of globalization that make Texas a “ground zero” for new infectious tropical diseases and outlines steps the state must take to better mitigate global health threats.
Current medical research and literature may be overemphasizing the role that hospital volume plays in patient outcomes, according to a study co-authored by health economics fellow Vivian Ho.
Woohyeon Kim, Stephen Wolff, Vivian HoApril 15, 2016
This study shows that HIV prevention is not a priority within Jordan’s health sector and that young people are at a greater risk of infection due to the paucity of sex education and youth-targeted HIV prevention programming.
Texans who bought their own health insurance were less likely to understand basic terms and how to use their plans compared to those with Medicare, Medicaid or employee-sponsored health insurance.
High cancer drug prices reduce access to therapy, cause treatment abandonment and financial bankruptcies, as well as severe emotional and family distress.
Approximately 25 percent of Texans say they lack confidence in understanding some of the most basic terminology about health insurance plans, according to a new report released March 8 by Rice University’s Baker Institute for Public Policy and the Episcopal Health Foundation.
This issue brief argues that continued investments in global health and the study of emerging pathogens could yield better tools to fight infectious diseases like the Zika virus long before they become a problem in the developed world.
Jennifer R. Herricks, Kirstin R.W. MatthewsMarch 4, 2016
Health Policy Scholar Quianta Moore examines legal and ethical justifications for permitting high-risk adolescents to consent to HIV prevention therapy in the Health Policy Forum’s March 2016 newsletter.